871 related articles for article (PubMed ID: 22423127)
1. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
Witt MA; Katz PH; Witt DJ
Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
4. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
Matter HC; Schmidt-Schläpfer G; Zimmermann H
Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
[TBL] [Abstract][Full Text] [Related]
6. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.
Sotir MJ; Cappozzo DL; Warshauer DM; Schmidt CE; Monson TA; Berg JL; Zastrow JA; Gabor GW; Davis JP
Arch Pediatr Adolesc Med; 2008 Jan; 162(1):79-85. PubMed ID: 18180417
[TBL] [Abstract][Full Text] [Related]
7. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
[TBL] [Abstract][Full Text] [Related]
8. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
9. Waning protection after fifth dose of acellular pertussis vaccine in children.
Klein NP; Bartlett J; Rowhani-Rahbar A; Fireman B; Baxter R
N Engl J Med; 2012 Sep; 367(11):1012-9. PubMed ID: 22970945
[TBL] [Abstract][Full Text] [Related]
10. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
[TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
[TBL] [Abstract][Full Text] [Related]
12. New pertussis vaccination approaches: en route to protect newborns?
Locht C; Mielcarek N
FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
[TBL] [Abstract][Full Text] [Related]
13. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
14. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
15. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of acellular pertussis vaccine in young infants.
Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
[TBL] [Abstract][Full Text] [Related]
19. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an acellular pertussis vaccine among adolescents and adults.
Ward JI; Cherry JD; Chang SJ; Partridge S; Lee H; Treanor J; Greenberg DP; Keitel W; Barenkamp S; Bernstein DI; Edelman R; Edwards K;
N Engl J Med; 2005 Oct; 353(15):1555-63. PubMed ID: 16221778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
